European Union (EU) authorities discussed several Coronavirus-related items, including an expansion of vaccine manufacturing and the detection of new strains, during Monday’s response meeting.
European Commission President Ursula von der Leyen said.
“Today’s #COVID19 response meeting focused on, Further boosting research with EU funds, Ramping up sequencing to detect new variants, Working with companies to expand vaccine manufacturing at scale, Bio-defence preparedness, Supporting our partners via COVAX & donations,’’ von der Leyen tweeted.
Previously, Brussels was involved in a row with UK-Swedish pharmaceutical company AstraZeneca over delays in deliveries due to issues at the firm’s production site in Belgium.
Sputnik
